vxrt earnings date 2021

Current and historical EBIT (Earnings Before Interest & Taxes) margin for VAXART, INC (VXRT) over the last 10 years. 2 analysts expect Vaxart, Inc. to make $750Million in revenue for the quarter ending June 01, 2021. Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Revenue is forecast to decline -16.7% this quarter before falling -87.5% for the next one. The following presents a detailed Vaxart stock price history for your review. 5 Day. Fiscal Yr 12/2021. February 24, 2021 - 4:01 pm. Last Payout Amount $0.00. -0.01 / -0.01. Days to Next Earnings: (Accesswire) IBM projects full-year 2021 adjusted cash flow between $11 billion and $12 billion, up from $10.8 billion in 2020, and between $12 billion and $13 billion in 2022. Earnings Estimates. -0.15. The extension is due to the submission of a response to an information request by the FDA, including additional analyses and clinical data, which the FDA will require additional time for review. The consensus estimate was a loss of $0.10 per share on revenue of $0.7 million. VXRT closed down 1.05 percent on Friday, May 28, 2021, on 22 percent of normal volume. VXRT 6.87 0.20 (2.83%). 3 Healthcare Stocks to Sell Before 2021 ... back up to $45. View the VXRT U.S. Securities and Exchange Commission reporting information. Vaxart (VXRT) has been actively engaged in developing a coronavirus vaccine. Revenue / Forecast. The latest price target for Vaxart ( NASDAQ: VXRT) was reported by HC Wainwright & Co. on 2020-08-12. VXRT Profile. Option traders are pricing in a 24.9% move on earnings and the stock has averaged a 8.8% move in recent quarters. 1 Day. NEW YORK, NY / ACCESSWIRE / March 2, 2021 / Vaxart, Inc. (NASDAQ:VXRT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 2, 2021 at 4:30 PM Eastern Time. The rise to weekly highs of $7.57- on Monday, Jun 07 increased the stock’s daily price by 3.04%. The new PDUFA date is June 7, 2021. Meet. 5-Year Growth N/A. Security Date/Time Rebate Rate Fee Rate Shares Available; VAXART INC VXRT: 2021-05-31 22:15:03 UTC-6.9465: 6.9865: 60000: VAXART INC VXRT: 2021-05-31 21:45:03 UTC On Friday, March 5, 2021 there was some notable buying of 3,545 contracts of the $20.00 call expiring on Friday, April 16, 2021. Sector: None Short Interest: 27.88. Up. Earnings Estimates. Vaxart Stock Earnings Report NASDAQ:VXRT Current P/E ratio: -16.54 | Price (May 24, 2021, EOD): $6.35 (Find current average P/E ratios for all sectors below ) VXRT Upcoming Earnings Get Vaxart Inc (VXRT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Average Estimate. Analysts have predicted the quarterly earnings per share to grow by -$0.14 per share this quarter, however they have predicted annual earnings per share of -$0.74 for 2021 and -$0.17 for 2022. VXRT: VAXART, INC. - Earnings Announcements. Post-Market 0.06 (0.87%) Ex-Dividend Date N/A. Next reporting date: August 12, 2021: EPS forecast (this quarter)-$0.14: Annual revenue (last year) $4.0M: Annual profit (last year)-$32.2M: Net profit margin Next Vaxart, Inc. - Common Stock earnings date is Aug 12, the estimation is 0.00. Underdog player Vaxart (NASDAQ: VXRT) is having an incredible day — VXRT stock is up almost 50%. Next Vaxart, Inc. - Common Stock earnings date is Aug 12, the estimation is 0.00. ... What do you expect when VXRT reports earnings? You can read further details here Post-Market 0.06 (0.87%) But the analysts are tempering their growth estimates for the 2021 fiscal year. The day’s price range saw the stock hit a low of $5.15, while the highest price level was $5.45. The company’s shares are currently up 0.29% year-to-date, but still up 0.1088 over the last five days. It is on Thu 18 Mar (In 70 Days). Latest Release. It means analysts are expecting annual earnings per share growth of 1.06% this year and … Date Trades. Sentiment › … Flat. Price as of: MAY 28, 12:00 PM EDT. Price target in 14 days: 7.384 USD. Vaxart, Inc. to Host Earnings Call. (VXRT) delivered earnings and revenue surprises of -40.00% and -17.99%, respectively, for the quarter ended March 2021. The next estimated earnings date is August 5, 2021, which is a Thursday. 6 Month. Check out just a few of the year-to-date moves coming into Thursday on 8 companies you've never heard of before the last week or two. VXRT 's fiscal year ends in December. Document Date. Before the announcement of TSLA’s Q1 2021 earnings … Vaxart (NASDAQ:VXRT) has made an awesome move recently with volume backed confirmation before the event at the World Vaccine Congress Washington 2021 that will be held virtually from May 4-6, 2021. Live Interactive Chart. On the other hand, Vaxart, Inc. (NASDAQ:VXRT) is 0.02% up in the 30-day period. Type. Shares of Vaxart (NASDAQ: VXRT) climbed on Tuesday after the biotech released promising data from a clinical trial of its oral coronavirus vaccine candidate. Vaxart Inc NASDAQ Updated Jun 4, 2021 11:55 PM. SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that Andrei Floroiu, CEO and Sean Tucker, CSO of the Vaxart executive team are … Earnings News. Novavax last issued its earnings data on May 10th, 2021. EPS / Forecast. Category. VXRT Stock Gets a Boost Ahead of T-Cell Seminar. VXRT Earnings. VXRT: Get the latest Vaxart stock price and detailed information including VXRT news, historical charts and realtime prices. To help provide a sense of the short to long-term trend, included is an interactive Vaxart stock chart which you can easily adjust to the time frame of your choosing (e.g. VXRT 6.87 0.20 (2.83%). $6.62 -0.07 -1.05%. May 03, 2021. Or Login to Your Premium Account. 0.00. Dividend Rate-- Ex-Dividend Date-- Dividend Payment Date-- Dividend Frequency. VXRT's market cap is 810.00 Million. Earnings Cycle. Vaxart to Present at the Jefferies Virtual Healthcare Conference. The company report on March 25, 2021 that ORMP: Company Advancing Oral COVID-19 … Earnings History: Past Earnings Statistics and Earnings Trendline. SOUTH SAN FRANCISCO, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT ), a clinical-stage biotechnology company developing oral vaccines that are administered by room-temperature stable tablet rather than by injection, today reported financial results for the first quarter ended March 31, 2021 and provided a corporate update. When it comes to the year-to-date metrics, the Vaxart Inc. (VXRT) recorded performance in the market was -2.45%, having the revenues showcasing -20.99% on a quarterly basis in comparison with the same period year before. During their last earnings release the company posted EPS of $-0.12. There are no upcoming events for VXRT. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Vaxart 's earnings in 2021 is -$46,930,000.On average, 2 Wall Street analysts forecast VXRT's earnings for 2021 to be $-91,089,997, with the lowest VXRT earnings forecast at $-105,150,870, and the highest VXRT earnings forecast at $-77,029,125. Beat. Vaxart, Inc. - Common Stock trades on the NASDAQ. Vaxart Stock Forecast, VXRT stock price prediction. -We do not have a set dividend date for Vaxart Inc at this time. The current EBIT profit margin for VAXART, INC as of March 31, 2021 is . VXRT's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 101 out of 146 industries, VXRT ranks higher than 37% of stocks. Vaxart Inc has risen 5.31% over the past month, closing at $6.33 on December 28. EPS / Forecast. Vaxart Inc. analyst estimates, including VXRT earnings per share estimates and analyst recommendations. NasdaqCM:VXRT Earnings and Revenue Growth January 20th 2021 We note that hedge funds don't have a meaningful investment in Vaxart. The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters and met the same once, with the average surprise being … Vaxart (VXRT) reported a 1st Quarter March 2021 loss of $0.14 per share on revenue of $0.5 million. *DJ Vaxart: Four Clinical Trials of the Oral Norovirus Vaccine Candidate to Be Initiated in 2021 >VXRT VXRT ... Next Earnings Date. Important Dates for Investors in VXRT:-Vaxart Inc is set to release earnings on 3/18/2021. Get the latest stock price for Vaxart Inc. (VXRT:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Why? VXRT | Vaxart short interest and earnings date annual report Apr, 2021. Vaxart Inc NASDAQ Updated Jun 4, 2021 11:55 PM. GKP Gulf Keyst.. LSE. Where is VXRT's stock price going from here? In the Biotechnology industry which is number 88 by this metric, VXRT ranks better than 47% of stocks. At the time of this writing, the total market value of the company is set at 665.17M, as it employees total of 28 workers. Knowing PMAEA for VXRT three weeks before Earnings Announcement can provide unique advantages in trading Earnings. Vaxart, Inc. (VXRT) - NASDAQ. Q4 2020 Earnings Release-$0.13 Q1 2021 Earnings Release-$0.14-$0.12 to -$0.08-$0.02. To read the full story on Seeking Alpha, click here. The company’s shares are currently up 0.29% year-to-date, but still up 0.1088 over the last five days. VXRT Dividends. Vaxart Stock Forecast, VXRT stock price prediction. Market data provided by Xignite. Next reporting date: August 12, 2021: EPS forecast (this quarter)-$0.14: Annual revenue (last year) $4.0M: Annual profit (last year)-$32.2M: Net profit margin using the … May. EVR: 3.3. Tesla’s (NASDAQ:TSLA) first-quarter earnings call will be on Monday, April 26, 2021, at 2:30 pm Pacific Time or 5:30 pm Eastern Time. Do the numbers hold clues to what lies ahead for the stock? VXRT has an average analyst recommendation of Strong Buy. The company has an average price target of $17.67. VXRT has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on VXRT! ... a recap of their last earnings report; and a … Vaxart, Inc. (NASDAQ:VXRT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 2, 2021 at 4:30 PM Eastern Time. The company’s sales for the same quarter a year ago was $2.8 Million. Revenue fell 82.6% compared to the same quarter a year ago. Fiscal Yr 12/2022. -0.14. Vaxart recovers day after shares take post-earnings drubbing May 04, 2021 By: Jonathan M Block, SA News Editor Vaxart (NASDAQ:VXRT) shares are up more than 9.3% in late afternoon trading, a day after the stock dropped 26% due to disappointing Q1 earnings and a delay in a phase 2 trial of its oral COVID-19 vaccine candidate. As of 3:30 p.m. EDT, Vaxart's stock price was up more than 12%. vxrt earnings date : Related News. 2021-08-05. In the same quarter last year, Vaxart's earnings per share (EPS) was -$0.02. Current Qtr 06/2021. Vaxart last released … The current EBIT profit margin for VAXART, INC as of March 31, 2021 is . Next Earnings Date: Estimate: Aug. 5, 2021 BO. Feb 27, 2020 10:51 AM EST Quant Rating on 2:04 PM EDT 6/4/2021 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it will host a conference call and provide a business update at 4:30 PM ET on Tuesday, March 2, 2021. Aviragen Therapeutics, Inc. has confirmed Earnings date and time. VXRT: NASDAQ (Stock) Vaxart Inc. Dividend policy. Next Earnings Date: Estimate: Aug. 5, 2021 BO. Overall earnings estimates have been revised lower since the company's last earnings release. Our data shows that RA Capital Management, L.P. is the largest shareholder with 9.9% of shares outstanding. 9. Dividend History. Total Vaxart earnings for the quarter were -$16.01 million. Financial summary of Vaxart, Inc. - Common Stock with all the key numbers The current VXRT market cap is 805.749M. Recently in News on March 2, 2021, Vaxart, Inc. to Host Earnings Call. The biopharmaceutical company reported ($3.05) earnings per share for the quarter, missing the consensus estimate of ($2.65) by $0.40. (VXRT) Reports Q1 Loss, Misses Revenue Estimates Zacks Investment Research 2021-05-03 10:31:16 EDT • Why Vaxart Stock Is Soaring Today The Motley Fool 2021-04-30 18:17:30 EDT • VXRT Stock: The Big Vaccine News Sending Vaxart Soaring Today InvestorPlace 2021 … Mar 02, 2021. 0.00. Dividend Yield. VXRT: Get the latest Vaxart stock price and detailed information including VXRT news, historical charts and realtime prices. Date Event description Earnings per share actual Earnings estimate range Previous year's actual; May 3, 2021. Upgrade Now. Price target in 14 days: 7.384 USD. Financial summary of Vaxart, Inc. - Common Stock with all the key numbers The current VXRT market cap is 809.417M. We expect investors’ focus to be on the progress of Vaxart, Inc.’s VXRT coronavirus vaccine program when the company reports second-quarter 2020 results.In the last reported quarter, the company delivered an earnings surprise of 50.00%. ... FY Report Date: 12/2021: Last Quarter's Earnings-0.14: Year Ago Earnings-0.28: The firm had revenue of $447 million for the quarter, compared to analysts' expectations of $233.90 million. EVR: Even at that price, the company's shares are expensive, with a price-to-earnings … VXRT on Yahoo! Finance Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. VXRT Vaxart Inc Vaxart recovers day after shares take post-earnings drubbing. Average Estimate. Amended. A. Investor; Trader; ... 2021 EarningsWhispers - the professionals' earnings expectation. NEW YORK, NY / ACCESSWIRE / March 2, 2021 / Vaxart, Inc. (NASDAQ:VXRT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call … SAN DIEGO, April 8, 2021 /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company ®, today announced the company will release its operating results for the quarter ended March 31, 2021 after the market closes on May 3, 2021. ... Next EPS Report Date: 8/5/2021: Research for VXRT. The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) for VXRT three weeks prior to earnings date. The latest earnings per stock, revenues and financial reports for Purple Biotech (PPBT). 3 Month. Annual Data | Millions of US $ except per share data; Cash on hand: Receivables: Inventory: Pre-Paid Expenses: Other Current Assets: Total Current Assets The rise to weekly highs of $7.57- on Monday, Jun 07 increased the stock’s daily price by 3.04%. VXRT: VAXART, INC. - Full Company Report. In trading on Thursday, shares of Vaxart Inc (VXRT) crossed above their 200 day moving average of $7.04, changing hands as high as $7.37 per share. The latest earnings per stock, revenues and financial reports for Vaxart Inc (VXRT). Date Type Description; 08/06/2021 : Earnings Results: Q2 2021 Earnings Results: 02/25/2021 : Earnings Results: Q4 2020 Earnings Results: 11/12/2020 : Earnings Results From Market News Video May 20, 2021. PPBT Earnings. Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 45% during past 5 years. -0.14. Updated 03/24/2021. Pivots. Consensus estimates provided by 2 financial analysts predict the company will bring in an average of $620Million in revenue for the current quarter. Next Qtr 09/2021. VXRT : 6.62 (-1.05%) An FDA Advisory Committee voted in November 2020 that the treatment was ineffective. Upgrade to Premium to access your Watchlist and more. Updated Jun 4, 2021 … In 2021, company’s earnings growth rate is likely to be around 57.8% while estimates for its earnings growth in next 5 years are of 0% Next Qtr 09/2021. Down. Get Post Earnings Performance For: Vaxart, Inc. (VXRT) - NASDAQ. Support: ... Thursday 3 June 2021 Your Recent History LSE. Fiscal Yr 12/2021. Vaxart, Inc. (VXRT) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. Past Earnings. The price action carved out a bearish shooting star candlestick pattern. Vaxart to Present at the Jefferies Virtual Healthcare Conference. To participate in the conference call: The conference code is 1813749. Latest Release. Avg Daily Volume: 16,361,364 Market Cap: 773.78M. Vaxart Inc. [NASDAQ: VXRT] closed the trading session at $5.35 on 04/16/21. Vaxart (NASDAQ: VXRT) reported Q1 2021 earnings per share (EPS) of -$0.14, up 600% year over year. Revenue / Forecast. SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that Andrei Floroiu, CEO and Sean Tucker, CSO of the Vaxart executive team are … Next Dividend Date. Accuray Inc (NASDAQ:ARAY) Q2 2021 Earnings Call Jan 27, 2021, 4:30 p.m. QPP Quindell FTSE. Fiscal Yr 12/2022. Next Earnings Release Date: 08/05/2021: Dividend Ex-Date: N/A: Last Dividend Amount: N/A: Dividend Yield: N/A: Dividend Frequency Per Year: N/A: Historical Volatility (30 day) 202.80%: Option Chart. Q3 2020 (Sep 2020) EPS of -$0.08 beat by $0.01 Revenue of $265.00K (-41.63% YoY) missed by -$0.80M. Thu, Feb 25, 2021 Since Q4 Earnings Report VXRT 14.6%. 14, 2021 -- Lear Corporation, a global automotive technology leader in Seating and E-Systems, will hold a conference call to review the company’s first quarter 2021 financial results and related matters on May 7,2021, at 8:30 a.m. EDT. Vaxart, Inc. has a market cap of $850.97 Million and is expected to release its quarterly earnings report on Aug 04, 2021- Aug 09, 2021. 3-Year Growth N/A. Current Qtr 06/2021. In-depth view of key statistics and finances for VAXART, INC. (VXRT) on MSN Money. Investors are likely to focus on progress of vaccine program on the Q2 earnings call. On the other hand, Vaxart, Inc. (NASDAQ:VXRT) is 0.02% up in the 30-day period. Realty Income Announces First Quarter 2021 Earnings Release Date. VXRT, REGI, ARVL and CRNT among premarket gainers Seeking Alpha - 5/4/2021 8:19:59 AM: Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2021 1:23:52 PM: Vaxart shares slide after first-quarter earnings miss Seeking Alpha - 5/3/2021 8:37:49 AM: Vaxart EPS misses by $0.04, misses on revenue Seeking Alpha - 5/3/2021 8:19:03 AM ... 10:48a Here Are the 11 Best Performing IPOs of 2021 ... Filing Date. The technical daily chart above shows the stock is in a bull market rally as MACD is on top of signal line and %K line is on top of %D line. Vaxart, Inc. (VXRT) shares are -7.58% down over the last 6 months, with its year-to-date growth rate lower than industry average at -108.33% against 16.3%. Miss. 1, 2021 - www.nasdaq.comToday's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on … Current and historical EBIT (Earnings Before Interest & Taxes) margin for VAXART, INC (VXRT) over the last 10 years. VXRT price target in 14 days: 9.867 USD* upside and 6.726 USD* downside. (Highest and lowest possible predicted price in a 14 day period) Get Our PREMIUM Forecast Now, from ONLY $7.49! ET. Next Earnings Release Date - 05/11/21. (VXRT) Reports Q1 Loss, Misses Revenue Estimates Zacks Investment Research 2021-05-03 10:31:16 EDT • Why Vaxart Stock Is Soaring Today The Motley Fool 2021-04-30 18:17:30 EDT • VXRT Stock: The Big Vaccine News Sending Vaxart Soaring Today InvestorPlace 2021 … Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. 1, 2021 - seekingalpha.comSeeking Alpha Catalyst Watch - Seeking Alpha; finance.yahoo.comVaxart (VXRT) to Report Q3 Earnings: What's in the Cards?- Yahoo Finance; www.marketbeat.comVXRT Earnings Date, Forecast and Report (Vaxart) - MarketBeat; May. Vaxart (VXRT) Recent Earnings. That may indicate a downside reversal. Sector Analysis. February 25, 2021. Vaxart is announcing today its coming key opinion leader webinar on the importance of T … Earnings Vaxart (NASDAQ:VXRT) Earnings Information. Company Information. Southfield, Mich., Apr. Next reporting date: August 12, 2021: EPS forecast (this quarter)-$0.14: Annual revenue (last year) $4.0M: Annual profit (last year)-$32.2M: Net profit margin Vaxart Inc. (NASDAQ:VXRT) shares are trading sharply higher Tuesday after the stock was trending on StockTwits. Earnings Date: Aug 04, 2021 - Aug 09, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: Nov 09, 2012: 1y Target Est: 13.33 With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the VXRT stock to lose ahead of the earnings release. Novavax (NASDAQ:NVAX) Earnings Information. Quotes delayed at least 15 minutes. For the fiscal year ending Dec 2021, the consensus EPS* forecast has remained the same over the past week at -0.75 and decreased over the past month from -0.67 to -0.75 (11.94%). The analyst firm set a price target for 17.00 expecting VXRT … -0.14 / -0.1. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Next Earnings Release Date - 05/11/21. -0.15. On Monday, the company announced it will host a key opinion leader webinar on the importance of T-Cell responses for COVID-19 vaccines on Monday, May 3, 2021. None.

__dopostback Selenium, Alabama Governor Coronavirus, Savannah Dolphin Tours, Unlink Skype From Microsoft 2020, Pittsburgh Penguins Merchandise Australia, Introduction To Religious Life, How To Make Items Stack On Ark Nitrado Servers, Harvard Reading List 2021, How Many Starbucks In London, Virtualbox Port Forwarding Connection Refused,